VantAI · 13 hours ago
Senior Project Manager
Proxima is building a computational pipeline to revolutionize drug discovery and development. They are seeking a highly motivated and experienced Senior Project Manager to oversee collaboration projects with biopharmaceutical partners and manage internal R&D pipelines.
Alternative MedicineArtificial Intelligence (AI)BiotechnologyClinical TrialsLife ScienceMachine Learning
Responsibilities
Lead cross-functional teams to ensure successful launches of collaboration projects
Align with external partners on project objectives, timelines and deliverables
Partner with project leaders to define scope, develop project plans and timelines, monitor and communicate project progress to stakeholders
Proactively manage project schedules, identify risks and help solve issues in a timely manner
Facilitate meetings, prepare meeting agendas and meeting minutes
Foster effective communication and collaboration amongst various parties
Manage project documentation and ensure compliance
Develop and implement project management best practices
Play an alliance manager role, building and maintaining relationships between internal team members and external partners
Qualification
Required
B.S./M.S. in Life Science(s), Computer Science, Computational Chemistry, Computational Biology, Engineering, Business or related fields
Demonstrated ability to work cross-functionally with multiple teams including Biology, Chemistry, Comp Bio, Comp Chem, Software Engineering and Machine Learning
Ability to manage multiple projects simultaneously and prioritize competing demands
5-10 years of work experience in a biotech or pharmaceutical environment
1-3 years in a project management role
Familiar with drug development pipelines and experience managing collaborations with external partners
Knowledge of project management tools and methodologies (PM certification is a plus)
Company
VantAI
VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases.
Funding
Current Stage
Early StageTotal Funding
$80MKey Investors
DCVC
2026-01-13Seed· $80M
Recent News
2025-10-30
Company data provided by crunchbase